Income Statement (TTM)
Jacobio Pharmaceuticals Group Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 243 | 486 | 515 | 544 | 348 | 153 | 151 | 150 | 123 | 96 | 89 | 81 | 72 | 64 | 43 | 23 | 89 | 156 | 179 | 201 |
| Change (%) | 100.00 | 5.93 | 5.60 | -35.95 | -56.14 | -0.98 | -0.99 | -18.04 | -22.02 | -7.49 | -8.10 | -10.98 | -12.33 | -31.75 | -46.52 | 285.79 | 74.08 | 14.66 | 12.79 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 22 | 44 | 71 | 97 | 119 | 140 | 136 | 133 | 108 | 83 | 79 | 75 | 68 | 60 | 41 | 22 | 11 | |||
| Change (%) | 100.00 | 60.22 | 37.59 | 21.97 | 18.01 | -2.60 | -2.67 | -18.68 | -22.98 | -4.77 | -5.00 | -9.89 | -10.98 | -31.44 | -45.87 | -50.00 | ||||
| % of Revenue | 9.07 | 9.07 | 13.72 | 17.88 | 34.05 | 91.60 | 90.11 | 88.58 | 87.89 | 86.80 | 89.37 | 92.38 | 93.51 | 94.96 | 95.38 | 96.55 | 12.51 | |||
| Gross Operating Profit | 221 | 442 | 444 | 447 | 230 | 13 | 15 | 17 | 15 | 13 | 9 | 6 | 5 | 3 | 2 | 1 | 78 | 156 | 179 | 201 |
| Change (%) | 100.00 | 0.52 | 0.51 | -48.56 | -94.42 | 16.67 | 14.29 | -13.07 | -15.04 | -25.45 | -34.14 | -24.18 | -31.89 | -37.50 | -59.99 | 9,669.60 | 98.98 | 14.66 | 12.79 | |
| % of Revenue | 90.93 | 90.93 | 86.28 | 82.12 | 65.95 | 8.40 | 9.89 | 11.42 | 12.11 | 13.20 | 10.63 | 7.62 | 6.49 | 5.04 | 4.62 | 3.45 | 87.49 | 100.00 | 100.00 | 100.00 |
| SG&A | 65 | 54 | 57 | 60 | 52 | 45 | 47 | 49 | 46 | 43 | 43 | 43 | 45 | 47 | 45 | 44 | 44 | 43 | 42 | 40 |
| Change (%) | -17.45 | 5.72 | 5.41 | -12.85 | -14.74 | 4.77 | 4.55 | -6.43 | -6.87 | 1.10 | 1.09 | 3.60 | 3.47 | -2.71 | -2.78 | -1.18 | -1.19 | -3.06 | -3.16 | |
| % of Revenue | 26.82 | 11.07 | 11.05 | 11.03 | 15.01 | 29.17 | 30.87 | 32.59 | 37.21 | 44.44 | 48.57 | 53.43 | 62.18 | 73.39 | 104.61 | 190.17 | 48.71 | 27.65 | 23.37 | 20.07 |
| R&D | 171 | 186 | 211 | 237 | 259 | 281 | 308 | 336 | 391 | 446 | 457 | 468 | 420 | 372 | 361 | 350 | 340 | 330 | 288 | 247 |
| Change (%) | 8.80 | 13.62 | 11.99 | 9.35 | 8.55 | 9.78 | 8.91 | 16.36 | 14.06 | 2.49 | 2.43 | -10.21 | -11.37 | -2.94 | -3.03 | -2.89 | -2.97 | -12.66 | -14.50 | |
| % of Revenue | 70.29 | 38.24 | 41.01 | 43.49 | 74.26 | 183.78 | 203.76 | 224.13 | 318.23 | 465.45 | 515.67 | 574.75 | 579.74 | 586.15 | 833.53 | 1,511.30 | 380.44 | 212.05 | 161.52 | 122.44 |
| OpEx | 249 | 276 | 330 | 383 | 414 | 445 | 473 | 501 | 539 | 577 | 586 | 596 | 536 | 475 | 440 | 404 | 381 | 359 | 318 | 278 |
| Change (%) | 10.77 | 19.36 | 16.22 | 8.11 | 7.50 | 6.28 | 5.91 | 7.55 | 7.02 | 1.70 | 1.67 | -10.13 | -11.27 | -7.56 | -8.18 | -5.54 | -5.86 | -11.32 | -12.77 | |
| % of Revenue | 102.52 | 56.78 | 63.98 | 70.41 | 118.85 | 291.29 | 312.65 | 334.43 | 438.88 | 602.29 | 662.14 | 732.53 | 739.55 | 748.54 | 1,013.85 | 1,740.71 | 426.22 | 230.49 | 178.26 | 137.87 |
| Operating Income | -6 | 210 | 186 | 161 | -66 | -292 | -322 | -351 | -416 | -481 | -498 | -515 | -463 | -412 | -396 | -380 | -292 | -203 | -140 | -76 |
| Change (%) | -3,531.41 | -11.70 | -13.26 | -140.80 | 345.12 | 10.07 | 9.15 | 18.47 | 15.59 | 3.53 | 3.41 | -9.99 | -11.10 | -3.83 | -3.98 | -23.29 | -30.37 | -31.24 | -45.42 | |
| % of Revenue | -2.52 | 43.22 | 36.02 | 29.59 | -18.85 | -191.29 | -212.65 | -234.43 | -338.88 | -502.29 | -562.14 | -632.53 | -639.55 | -648.54 | -913.85 | -1,640.71 | -326.22 | -130.49 | -78.26 | -37.87 |
| Interest Expense | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -0 | -1 | -2 | -4 | -6 | -7 | -8 | -9 | -10 | -9 | -8 | -10 | -11 |
| Change (%) | -20.42 | -21.22 | -26.94 | 0.35 | 0.35 | -15.58 | -18.46 | 240.28 | 70.61 | 80.29 | 44.53 | 20.26 | 16.85 | 8.80 | 8.09 | -7.04 | -7.57 | 15.98 | 13.78 | |
| % of Revenue | -0.51 | -0.20 | -0.15 | -0.10 | -0.16 | -0.37 | -0.32 | -0.26 | -1.08 | -2.37 | -4.62 | -7.27 | -9.82 | -13.09 | -20.86 | -42.16 | -10.16 | -5.39 | -5.46 | -5.50 |
| Net Income | -1,298 | -1,514 | -1,177 | -839 | -570 | -301 | -297 | -292 | -332 | -372 | -391 | -410 | -385 | -359 | -361 | -362 | -259 | -156 | -101 | -46 |
| Change (%) | 16.65 | -22.27 | -28.66 | -32.06 | -47.19 | -1.46 | -1.48 | 13.58 | 11.96 | 5.17 | 4.92 | -6.24 | -6.65 | 0.39 | 0.38 | -28.49 | -39.83 | -35.34 | -54.66 | |
| % of Revenue | -533.69 | -311.27 | -228.39 | -154.30 | -163.69 | -197.10 | -196.16 | -195.19 | -270.52 | -388.38 | -441.56 | -504.11 | -530.96 | -565.36 | -831.57 | -1,560.88 | -289.33 | -100.00 | -56.39 | -22.67 |
Source: Capital IQ
